Shares of PYC Therapeutics (ASX:PYC) were flat in early trading on Tuesday after it reported late Monday a fiscal first-half loss of AU$0.0391 per share, compared with AU$0.0548 a year earlier.
Revenue for the six months ended Dec. 31, 2025, was AU$11 million, compared with AU$12.7 million a year earlier.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.